Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:27 pm Sale | 2023-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 5,750,882 4.200% | -1,250,000 (-17.85%) | Filing History |
| 2023-05-03 4:36 pm Purchase | 2023-04-30 | 13D | Midwest Holding Inc. MDWT | BRATTON DOUGLAS K | 445,171 11.900% | 445,171 (New Position) | Filing History |
| 2023-02-13 4:14 pm Sale | 2022-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 7,000,882 5.200% | -844,307 (-10.76%) | Filing History |
| 2022-12-21 5:02 pm Sale | 2022-12-14 | 13G | Altitude Acquisition Corp. ALTU | BRATTON DOUGLAS K | 0 0.000% | -70,573 (Position Closed) | Filing History |
| 2022-12-13 5:01 pm Purchase | 2022-12-07 | 13G | Altitude Acquisition Corp. ALTU | BRATTON DOUGLAS K | 70,573 4.200% | 70,573 (New Position) | Filing History |
| 2022-11-18 11:01 am Unchanged | 2022-11-08 | 13G | Royalty Management Holding Corporation RMCO | BRATTON DOUGLAS K | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:37 pm Sale | 2021-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 7,845,189 6.400% | -4,503,595 (-36.47%) | Filing History |
| 2022-02-11 4:03 pm Sale | 2021-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 10,117,434 25.200% | -1,494,320 (-12.87%) | Filing History |
| 2021-02-12 4:19 pm Sale | 2020-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 12,348,784 10.300% | -8,066,751 (-39.51%) | Filing History |
| 2021-02-09 3:19 pm Purchase | 2020-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 11,611,754 34.500% | 26,700 (+0.23%) | Filing History |
| 2020-05-04 2:27 pm Purchase | 2020-04-24 | 13D | Midwest Holding Inc. MDWT | BRATTON DOUGLAS K | 444,444 16.300% | 444,444 (New Position) | Filing History |
| 2020-02-12 4:34 pm Purchase | 2019-12-31 | 13G | Aquestive Therapeutics, Inc. AQST | BRATTON DOUGLAS K | 11,585,054 46.300% | 6,675 (+0.06%) | Filing History |
| 2020-02-11 4:00 pm Sale | 2019-12-31 | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 20,415,535 21.300% | -158,763 (-0.77%) | Filing History |